×
About 55,860 results

ALLMedicine™ Hepatitis C Virus Center

Research & Reviews  27,485 results

Sphingomyelin Is Essential for the Structure and Function of the Double-Membrane Vesicl...
https://doi.org/10.1128/JVI.01080-20
Journal of Virology; Gewaid H, Aoyagi H et. al.

Sep 17th, 2020 - Some plus-stranded RNA viruses generate double membrane vesicles (DMVs), one type of the membrane replication factories, as replication sites. Little is known about the lipid components involved in the biogenesis of these vesicles. Sphingomyelin (...

Association of the Polymorphism of the Toll-like Receptor (TLR) 3 and TLR9 Genes with H...
https://doi.org/10.1111/cei.13514
Clinical and Experimental Immunology; Abdelwahab SF, Hamdy S et. al.

Sep 17th, 2020 - Variations in the immune response could explain resistance to hepatitis C virus (HCV) infection. Toll-like receptor gene (TLR)-3 is an innate detector of dsRNA viruses, and the TLR9 gene recognizes bacterial and viral unmethylated CpG motifs. We p...

Platelet Count Improvement after Chronic Hepatitis C Treatment among Cirrhotic Patients...
https://doi.org/10.2174/1871530320666200917113650
Endocrine, Metabolic & Immune Disorders Drug Targets; Badawi R, Soliman S et. al.

Sep 17th, 2020 - This study aimed to assess the changes in platelet counts of patients with liver cirrhosis due to chronic HCV, who achieved sustained virological response (SVR) after taking direct acting antivirals (DAAs) in a large cohort study in Egypt. This mu...

Reticulon-3 modulates the incorporation of replication competent hepatitis C virus mole...
https://doi.org/10.1371/journal.pone.0239153
PloS One; Li J, Abosmaha E et. al.

Sep 17th, 2020 - Cell released microvesicles specifically, exosomes, play an important role in mediating immunologic escape, treatment resistance, and disease persistence of Hepatitis C virus (HCV) infection. Reports on the molecular compositions of exosomes relea...

Will peer-based interventions improve hepatitis C virus treatment uptake among young pe...
https://doi.org/10.17269/s41997-020-00413-3
Canadian Journal of Public Health = Revue Canadienne De Sante Publique; Jacob J, Ti L et. al.

Sep 16th, 2020 - People who inject drugs (PWID) are disproportionately affected by hepatitis C virus (HCV) and have low rates of direct-acting antiviral (DAA) treatment uptake, despite universal coverage of the medication in most Canadian settings. Investigation i...

see more →

Guidelines  45 results

Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline
https://annals.org/aim/fullarticle/2751913/prevention-diagnosis-evaluation-treatment-hepatitis-c-virus-infection-chronic-kidney

Sep 23rd, 2019 - Description: The Kidney Disease: Improving Global Outcomes (KDIGO) 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) infection in chronic kidney disease (CKD) is an extensive updat...

Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chro...
https://doi.org/10.7326/M19-1539
Annals of Internal Medicine; Gordon CE, Berenguer MC et. al.

Sep 23rd, 2019 - This article has been corrected. The original version (PDF) is appended to this article as a Supplement. The Kidney Disease: Improving Global Outcomes (KDIGO) 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatmen...

FDA warns about rare occurrence of serious liver injury with use of hepatitis C medicines Mavyret, Zepatier, and Vosevi in some patients with advanced liver disease
https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-rare-occurrence-serious-liver-injury-use-hepatitis-c-medicines-mavyret-zepatier-and

Aug 27th, 2019 - The Food and Drug Administration (FDA) has received reports that the use of Mavyret, Zepatier, or Vosevi to treat chronic hepatitis C in patients with moderate to severe liver impairment has resulted in rare cases of worsening liver function or li...

HIV and Viral Hepatitis - CDC
https://www.cdc.gov/hiv/pdf/library/factsheets/hiv-viral-hepatitis.pdf

Jun 26th, 2019 - People with HIV infection are affected disproportionally by viral hepatitis. Nearly 75% of people with HIV who report a history of injection drug use also are infected with hepatitis C virus (HCV).

Hepatitis C Questions and Answers for Health Professionals
https://www.cdc.gov/hepatitis/hcv/hcvfaq.htm

Apr 8th, 2019 - What are the case definitions for reportable hepatitis C virus (HCV) infections? The specific viral cause of illness cannot be determined based solely on signs, symptoms, history, or current risk factors, but must be verified by specific serologic...

see more →

Drugs  33 results see all →

Clinicaltrials.gov  27,721 results

Sphingomyelin Is Essential for the Structure and Function of the Double-Membrane Vesicl...
https://doi.org/10.1128/JVI.01080-20
Journal of Virology; Gewaid H, Aoyagi H et. al.

Sep 17th, 2020 - Some plus-stranded RNA viruses generate double membrane vesicles (DMVs), one type of the membrane replication factories, as replication sites. Little is known about the lipid components involved in the biogenesis of these vesicles. Sphingomyelin (...

Association of the Polymorphism of the Toll-like Receptor (TLR) 3 and TLR9 Genes with H...
https://doi.org/10.1111/cei.13514
Clinical and Experimental Immunology; Abdelwahab SF, Hamdy S et. al.

Sep 17th, 2020 - Variations in the immune response could explain resistance to hepatitis C virus (HCV) infection. Toll-like receptor gene (TLR)-3 is an innate detector of dsRNA viruses, and the TLR9 gene recognizes bacterial and viral unmethylated CpG motifs. We p...

Platelet Count Improvement after Chronic Hepatitis C Treatment among Cirrhotic Patients...
https://doi.org/10.2174/1871530320666200917113650
Endocrine, Metabolic & Immune Disorders Drug Targets; Badawi R, Soliman S et. al.

Sep 17th, 2020 - This study aimed to assess the changes in platelet counts of patients with liver cirrhosis due to chronic HCV, who achieved sustained virological response (SVR) after taking direct acting antivirals (DAAs) in a large cohort study in Egypt. This mu...

Reticulon-3 modulates the incorporation of replication competent hepatitis C virus mole...
https://doi.org/10.1371/journal.pone.0239153
PloS One; Li J, Abosmaha E et. al.

Sep 17th, 2020 - Cell released microvesicles specifically, exosomes, play an important role in mediating immunologic escape, treatment resistance, and disease persistence of Hepatitis C virus (HCV) infection. Reports on the molecular compositions of exosomes relea...

Will peer-based interventions improve hepatitis C virus treatment uptake among young pe...
https://doi.org/10.17269/s41997-020-00413-3
Canadian Journal of Public Health = Revue Canadienne De Sante Publique; Jacob J, Ti L et. al.

Sep 16th, 2020 - People who inject drugs (PWID) are disproportionately affected by hepatitis C virus (HCV) and have low rates of direct-acting antiviral (DAA) treatment uptake, despite universal coverage of the medication in most Canadian settings. Investigation i...

see more →

News  573 results

Stick with the full 12-week DAA course for acute HCV
https://www.mdedge.com/gihepnews/article/219071/hepatitis/stick-full-12-week-daa-course-acute-hcv?channel=346
M. Alexander Otto, MDedge News

Mar 16th, 2020 - The first randomized trial to see if a short course of a direct-acting antiviral works as well for acute hepatitis C virus (HCV) infection as the standard 12-week course was stopped early after it became clear that it did not, according to a repor.

Screen all adults for hepatitis C, says USPSTF
https://www.mdedge.com/jcomjournal/article/218184/infectious-diseases/screen-all-adults-hepatitis-c-says-uspstf?channel=39313
Heidi Splete

Mar 2nd, 2020 - Adults aged 18-79 years should be screened for hepatitis C virus infection, according to an updated grade B recommendation from the U. S.

HCV a risk in HIV-negative MSM who use PrEP
https://www.mdedge.com/fedprac/article/215948/hiv/hcv-risk-hiv-negative-msm-who-use-prep?channel=314
Mark S. Lesney

Jan 22nd, 2020 - Hepatitis C virus (HCV) is known to be a common sexually transmitted infection (STI) among HIV-positive men who have sex with men (MSM). To examine this relationship in HIV-negative MSM, researchers in the Amsterdam PrEP Project team in the HIV Tr.

ED-based HCV screening found feasible, linkage low
https://www.mdedge.com/fedprac/article/212662/hepatology/ed-based-hcv-screening-found-feasible-linkage-low?channel=53
Will Pass

Nov 20th, 2019 - BOSTON – ED-based screening is a feasible method of detecting hepatitis C virus (HCV) in high-risk populations, but linkage to care remains low, according to investigators. Will Pass/MDedge News Dr.

Direct-acting antiviral treatment linked to lower mortality in patients with HCC history
https://www.mdedge.com/fedprac/avaho/article/212167/oncology/direct-acting-antiviral-treatment-linked-lower-mortality?channel=263
Andrew D. Bowser

Nov 12th, 2019 - BOSTON – For patients with a complete response following treatment for hepatitis C virus (HCV)–related hepatocellular carcinoma (HCC), treatment with direct-acting antiviral therapy was linked to significantly reduced mortality compared with no su.

see more →

Patient Education  3 results see all →